Haemonetics (HAE) Liabilities and Shareholders Equity (2010 - 2026)
Haemonetics (HAE) posted quarterly Liabilities and Shareholders Equity of $2.4 billion for Q1 2026, down 2.24% year-over-year from $2.5 billion in Q1 2025, and down 3.81% quarter-over-quarter from $2.5 billion in Q4 2025.
Haemonetics (HAE) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Haemonetics' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $2.4 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity fell 2.24% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $9.8 billion (down 2.56% YoY), while the FY2026 annual figure was $2.4 billion, down 2.24% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $2.4 billion, down from $2.5 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $2.5 billion in Q2 2024, with the low at $1.8 billion in Q3 2022.
- The 5-year median for Liabilities and Shareholders Equity is $2.2 billion (2023), against an average of $2.2 billion.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity surged 38.94% in 2022, then fell 3.29% in 2025.
- Haemonetics' Liabilities and Shareholders Equity stood at $1.9 billion in 2022, then grew by 17.16% to $2.2 billion in 2023, then advanced by 15.04% to $2.5 billion in 2024, then retreated by 1.6% to $2.5 billion in 2025, then slipped by 3.81% to $2.4 billion in 2026.
- Business Quant data shows HAE's Liabilities and Shareholders Equity at $2.4 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 2.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 2.37 Bn |
| Mar 28, 2026 | 2.40 Bn |
| Dec 27, 2025 | 2.49 Bn |
| Sep 27, 2025 | 2.44 Bn |
| Jun 28, 2025 | 2.46 Bn |
| Mar 29, 2025 | 2.45 Bn |
| Dec 28, 2024 | 2.53 Bn |
| Sep 28, 2024 | 2.53 Bn |
| Jun 29, 2024 | 2.54 Bn |
| Mar 30, 2024 | 2.20 Bn |
| Dec 30, 2023 | 2.20 Bn |
| Sep 30, 2023 | 2.01 Bn |
| Jul 1, 2023 | 1.96 Bn |
| Apr 1, 2023 | 1.93 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Oct 1, 2022 | 1.87 Bn |
| Jul 2, 2022 | 1.82 Bn |
| Apr 2, 2022 | 1.86 Bn |
| Jan 1, 2022 | 1.83 Bn |
| Oct 2, 2021 | 1.80 Bn |